Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Deutsche Krebshilfe
European Research Council
St. Baldrick's Foundation
- License Information
-
More Information
Article History
Received: 3 December 2021
Accepted: 30 March 2022
First Online: 20 May 2022
Declarations
:
: Not applicable.
: Not applicable.
: J. H. K. has advisory roles for bluebird bio, Novartis, Roche, and Jazz Pharmaceuticals. The authors disclose that their published work is highlighted in this mini review.
